This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Prices will rise in...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Laurent Knerr, Ph.D.
Principal Scientist at AstraZeneca
Speaker

Profile

Present affiliation and position:

  • Senior Director / Team Leader
  • Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Past affiliations:

  • PhD organic chemistry, Strasbourg University, France, 1998
  • Post-doctoral associate solid phase oligosaccharide synthesis, Konstanz University, Germany 1998-1999
  • Team Leader, parallel synthesis and automation group, UCB Pharma, Braine l’Alleud, Belgium 2000-2003

Current specific interests:

  • Medicinal chemistry beyond small molecules
  • Peptides and peptide conjugates as therapeutics
  • Targeted drug delivery
  • Bioconjugation
  • Drugging RNA and RNA/protein interfaces
  • Author or co-author of more than 50 peer reviewed research papers, patents, reviews and book chapter

Agenda Sessions

  • Design and Application of Novel Peptide Conjugates for the Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cells

    14:30